Loading...

Follow Biotechnology Patent Law Blog | Patents4Life by.. on Feedspot

Continue with Google
Continue with Facebook
or

Valid
Biotechnology Patent Law Blog | Paten..
Warren Woessner is Schwegman, Lundberg & Woessner, P.A., Minneapolis, MN,..
+
In Galderma Labs. v. Teva Pharm. USA, Inc., Appeal Nos. 2019-2396 and 2020-1213 (Fed. Cir,. January 29, 2020), a Fed. Cir. panel of Judges ..read more
On January 15, 2020, President Trump signed a lengthy “Economic and Trade Agreement Between the Government of the [US] and the ..read more
This morning, the Supreme Court denied the petitions for cert. filed in the Vanda, Berkheimer and Athena appeals. While the Court had ..read more
In Hulu v Soundview Innovations, IPR2018-01039, the PTAB was faced with the question of whether or not a certain textbook was a “printed ..read more
Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the Court should grant cert. in ..read more
A “catch 22” is defined as a “dilemma or difficult circumstance from which there is no escape because of mutually conflicting or ..read more
In Arthrex, Inc. v. Smith & Nephew, Inc., Appeal No. 2018-2140 (Fed. Cir., Oct. 31, 2019), a three Judge Fed. Cir. panel of Moore, ..read more
Guest post from Edward Sandor. Warren Woessner also posted a blog about the Updated Guidance on October 21. On October 17, 2019, the USPTO ..read more
On Oct. 17th, the PTO published Guidelines intended to supplement the Jan. 2019 Subject Matter Eligibility Guidelines (“2019 PEG”). ..read more
In OSI v. Apotex, Appeal no. 2018-1925 (Fed. Cir., October 4, 2019), the panel reversed the PTAB and found that the method of treatment ..read more

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview